KRT-232 and TKI Study in Chronic Myeloid Leukemia

Clinical trial NCT04835584 · UNKNOWN

Trial details

NCT number: NCT04835584
Sponsor: Kartos Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia

Start date: 2021-05-07
Primary completion: 2024-12-31
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.